Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 801-810 of 9364

Page
per page
  1. DC_AC50
    B5981 DC_AC50
    Summary: Selective Atox1 and CCS inhibitor
      Soluble in DMSO
  2. CHZ868
    B5980 CHZ868
     1 Citation
    Summary: Type II JAK2 inhibitor
      Soluble in DMSO
  3. CCT251545
    B5979 CCT251545
    Summary: Orally bioavailable and potent WNT signaling inhibitor
      ≥42.2 mg/mL
  4. BDA-366
    B5978 BDA-366
    Target: Bcl-2
    Summary: Selective antagonist of BCL2 BH4 domain
      ≥50.4 mg/mL
  5. Angiotensin III (human, mouse)
    A1043 Angiotensin III (human, mouse)
    Summary: Aldosterone stimulator
      ≥23.2 mg/mL
  6. MN 64
    B5983 MN 64
    Summary: tankyrase inhibitor
      insoluble in H2O; ≥11.65 mg/mL
  7. THZ2
    A8717 THZ2
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK7 inhibitor
      ≥28.3 mg/mL
  8. GX-674
    A8718 GX-674
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: Nav1.7 antagonist
      Soluble in DMSO
  9. ODM-201
    A8452 ODM-201
    Target: Androgen Receptors
    Summary: new-generation androgen receptor inhibitor
  10. ML 239
    A8719 ML 239
    Summary: inhibitor of the breast cancer stem cells
      Soluble in DMSO

Items 801-810 of 9364

Page
per page